{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:28Z","timestamp":1787314288810,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100021528","name":"Royal Victorian Eye and Ear Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.oret.2023.10.009","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:27:13Z","timestamp":1697491633000},"page":"325-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-2580","authenticated-orcid":false,"given":"Alison","family":"Hiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3916-4582","authenticated-orcid":false,"given":"Roderick","family":"O\u2019Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0040-9880","authenticated-orcid":false,"given":"Lotte S.","family":"Fog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0539-3515","authenticated-orcid":false,"given":"Daniel","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-6781","authenticated-orcid":false,"given":"Malaka","family":"Ameratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-4580","authenticated-orcid":false,"given":"Anthony M.","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-4655","authenticated-orcid":false,"given":"Mark","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.oret.2023.10.009_bib1","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.oret.2023.10.009_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/1535-7163.MCT-19-0098","article-title":"Genomic profiling of metastatic uveal melanoma and clinical results of a phase I study of the protein kinase C inhibitor AEB071","volume":"19","author":"Piperno-Neumann","year":"2020","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"10.1016\/j.oret.2023.10.009_bib3","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1158\/1535-7163.MCT-12-0121","article-title":"Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC\/Erk1\/2 and PKC\/NF-\u03baB pathways","volume":"11","author":"Wu","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"39","key":"10.1016\/j.oret.2023.10.009_bib4","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1038\/onc.2013.418","article-title":"Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.oret.2023.10.009_bib5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41416-022-02133-6","article-title":"A\u00a0phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma","volume":"128","author":"Piperno-Neumann","year":"2023","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.oret.2023.10.009_bib6","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-15-0370","article-title":"Paracrine effect of NRG1 and HGF drives resistance to MEK inhibitors in metastatic uveal melanoma","volume":"75","author":"Cheng","year":"2015","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.oret.2023.10.009_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.1990.01070110084030","article-title":"Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.oret.2023.10.009_bib9","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2023.10.009_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejmp.2022.08.001","article-title":"Analysis of the dose to the macula, optic disc, and lens in relation to vision toxicities \u2013 a retrospective study using COMS eye plaques","volume":"101","author":"Oare","year":"2022","journal-title":"Phys Med"},{"issue":"13","key":"10.1016\/j.oret.2023.10.009_bib11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.oret.2023.10.009_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.20.00605","article-title":"Nivolumab and ipilimumab in metastatic uveal melanoma: results from a single-arm phase II study","volume":"39","author":"Pelster","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.oret.2023.10.009_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.20.00550","article-title":"Nivolumab plus ipilimumab for treatment-na\u00efve metastatic uveal melanoma: an open-label multicenter, phase II trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)","volume":"39","author":"Piulats","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.oret.2023.10.009_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/cancers11081124","article-title":"Predicting visual acuity deterioration and radiation-induced toxicities after brachytherapy for choroidal melanomas","volume":"11","author":"Espensen","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.oret.2023.10.009_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","article-title":"Histopathologic characteristics of uveal melanomas in eyes nucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023005018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653023005018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T17:31:50Z","timestamp":1712597510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653023005018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2468653023005018"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2023.10.009","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2023.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}